FindTrial
Sign In

Postoperative Endocrine Inhibitor Therapy of Differentiated Thyroid Cancer: Development of an Online Dynamic Adjunctive Precision Dose-Adjustment System

Postoperative Endocrine Inhibitor Therapy of Differentiated Thyroid Cancer: Development of an Online Dynamic Adjunctive Precision Dose-Adjustment System

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043154
Enrollment
Unknown
Registered
2021-02-07
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

differentiated thyroid cancer

Interventions

Initial treatment period(Postoperative 1 year):Nil

Sponsors

Shanghai Jiao Tong University Affiliated with the Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age: 16-80 years old; 2. Pathologically confirmed differentiated thyroid carcinoma; 3. non-pregnant state; 4. Postoperative status of DTC; 5. Weight: 40-125kg.

Exclusion criteria

Exclusion criteria: 1. Clinical information is incomplete; 2. Unable to use network terminal APP; 3. patients with mental illness; 4. accompanied by serious basic diseases; 5. with other pathological types of thyroid cancer; 6. Refuse to sign the informed consent.

Design outcomes

Primary

MeasureTime frame
thyrotropin;—

Countries

China

Contacts

Public ContactFan Youben

Shanghai Jiao Tong University Affiliated with the Sixth People's Hospital

fanyouben2006@163.com+86 18930177562

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026